Event Details
Prior to document date
Description
Acquisition of Interlace Medical by Hologix
Participants (3)
| Name | Type | Mentions | |
|---|---|---|---|
| Hologix | organization | 3 | View Entity |
| New Leaf | organization | 90 | View Entity |
| ICA | organization | 1597 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024052.jpg
This document appears to be page 41 of a confidential investment memorandum for 'New Leaf,' specifically regarding their third fund, NLV-III. It outlines the 'Medical Devices Investment Strategy,' emphasizing a shift toward later-stage opportunities due to regulatory headwinds in the U.S. and E.U. The document cites specific portfolio successes like Neuronetics, CardioKinetix, and the acquisition of Interlace Medical by Hologix to demonstrate the team's track record.
Related Events
Events with shared participants
Spin-out of New Leaf from Sprout.
Date unknown • Unknown
Mexican government released list of 38 approved OTC cannabis products
2018-11-01 • Mexico
Projected legalization of cannabis for adult-use purposes
2019-01-01 • Mexico
Supreme Court decision regarding the broadcasting of Carlin's routine on Pacifica radio.
Date unknown • USA
Arizona Republican Party enacts a resolution declaring the US a 'Christian Nation'.
Date unknown • Arizona
First Iraq War
1990-01-01 • Iraq
Set up a Family Assistance Hotline within 10 days via an outsourcer
2005-01-01 • USA
Formation of Saudi American Bank
1980-01-01 • Saudi Arabia
FDA accepted GW Pharmaceuticals’ New Drug Application (NDA) for the cannabis-derived drug Epidiolex.
2017-10-01 • USA
Fundraising campaign in Saudi Arabia for Al Quds uprising (Intifada)
2000-01-01 • Saudi Arabia
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event